Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: Is the centers for disease control and prevention definition for community-acquired bacteremia still appropriate?

Infection Control and Hospital Epidemiology

Volumn 26, Issue 2, 2005, Pages 204-209

  Lesens, Olivier ^a   Hansmann, Yves ^b   Brannigan, Eimar ^d   Hopkins, Susan ^d   Meyer, Pierre ^c   O'Connel, Brian ^d   Prévost, Gilles ^c   Bergin, Colm ^d   Christmann, Daniel ^b  

^a HÔTEL DIEU   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; GENTAMICIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; FEMALE; FRANCE; HEALTH CARE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PULSED FIELD GEL ELECTROPHORESIS;

AGED; BACTEREMIA; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; INFECTION CONTROL; LOGISTIC MODELS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 15944379663     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502527     Document Type: Article

References (19)

1. Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13:50-55.
2. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003;37:1453-1460.
3. Lesens O, Méthlin C, Hansmann Y, et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003;24:890-896.
4. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-139.
5. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140.
6. Friedman ND, Kaye KS, Stout JE, et al. Health-care associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791-797.
7. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987;40:373-383.
8. Lesens O, Hansmann Y, Brannigan E, et al. Positive surveillance blood culture is a predictive factor for metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 2004;48:245-252.
9. Sekeres MA, Abrutyn E, Berlin JA, et al. An assessment of the usefulness of the Duke criteria for diagnosing active infective endocarditis. Clin Infect Dis 1997;24:1185-1190.
10. Lautenschlager S, Herzog C, Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus. Clin Infect Dis 1993;16:567-573.
11. Mylotte JM, McDermott C. Staphylococcus aureus bacteremia caused by infected intravenous catheters. Am J Infect Control 1987;15:1-6.
12. Prevost G, Jaulhac B, Piemont Y. DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol 1992;30:967-973.
13. Morin CA, Hadler JL. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001;184:1029-1034.
14. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis 1987;9:891-907.
15. Fowler VG Jr, Sanders LL, Sexton DJ. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-486.
16. Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Am J Med 1976;60:495-500.
17. Bayer AS, Lam K, Ginzton L, Norman DC, Chiu CY, Ward JI. Clinical, serologic, and echocardiographic findings in patients with and without endocarditis. Arch Intern Med 1987;147:457-462.
18. Lesens O, Hansmann Y, Storck D, Christmann D. Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. European Journal of Internal Medicine 2003;14:227-231.
19. Fowler VG, Li J, Corey R, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. Journal of the American College of Cardiology 1997;30:1072-1078.